NCT01218217View on ClinicalTrials.gov

Early Bactericidal Activity (EBA) of SQ109 in Adult Subjects With Pulmonary TB

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

May 31, 2012

Conditions
Tuberculosis, Pulmonary
Interventions
DRUG

SQ109

SQ109 150 mg tablet

DRUG

Rifampicin

Rifampicin 150 mg capsules

Trial Locations (2)

Unknown

TASK Applied Sciences, Cape Town

University of Cape Town, Cape Town

Sponsors
All Listed Sponsors
collaborator

Sequella, Inc.

INDUSTRY

collaborator

European and Developing Countries Clinical Trials Partnership (EDCTP)

OTHER_GOV

collaborator

German Federal Ministry of Education and Research

OTHER_GOV

collaborator

Quintiles, Inc.

INDUSTRY

collaborator

CMed Technologies Inc.

INDUSTRY

collaborator

PathCare

UNKNOWN

collaborator

Parexel

INDUSTRY

lead

Michael Hoelscher

OTHER